Rapamycin (LC Laboratories, Woburn, MA) was dissolved in 100% ethanol (30 mg/ml) and stored at −20°C until use. Immediately before injection, rapamycin was diluted (1:10) into vehicle (5% Tween80, 5% PEG400, 5% EtOH in 1× PBS). Moderately injured IGFtg and WT mice in a 3-day (Figure 1B) and a 10-day (Figure 1C) survival cohort were randomly assigned to either vehicle or rapamycin treatment groups for each experiment. The 3-day survival cohort received daily intraperitoneal (i.p.) injections of 10 mg/kg rapamycin (n = 3/genotype) or vehicle (n = 3/genotype) beginning 1 h after CCI. The 10-day survival cohort mice received a daily i.p. injection of 10 mg/kg rapamycin (n = 8/genotype) or vehicle (n = 6–7/genotype) beginning 1 h after the last BrdU injection.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.